CLARE ROEWE, APRN
Family Nurse Practitioner · OVERLAND PARK, KS
Individual Active NPI 1083221717
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 249 | 161,519 | $12,876,836 | $4,572,154 | $3,637,850 |
| 2023 | 181 | 89,171 | $7,686,191 | $2,631,160 | $2,092,193 |
| 2022 | 203 | 96,679 | $9,973,604 | $3,697,608 | $2,946,875 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J3380 | Injection, vedolizumab, intravenous, 1 mg | 22,200 | $22 | $17 |
| J2356 | Injection, tezepelumab-ekko, 1 mg | 14,910 | $18 | $14 |
| J2357 | Injection, omalizumab, 5 mg | 10,440 | $38 | $30 |
| J3032 | Injection, eptinezumab-jjmr, 1 mg | 8,500 | $18 | $15 |
| J1306 | Injection, inclisiran, 1 mg | 7,100 | $12 | $10 |
| J3245 | Injection, tildrakizumab, 1 mg | 4,800 | $135 | $107 |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 2,384 | $44 | $35 |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 1,570 | $31 | $25 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 997 | $0 | $0 |
| 96372 | Injection of drug or substance under skin or into muscle | 548 | $11 | $9 |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 206 | $48 | $38 |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 178 | $97 | $78 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Family Nurse Practitioner | 363LF0000X | ✓ | 2020032309 | MO |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- No
Other Family Nurse Practitioner providers in Kansas
- NPI 1467945618
- NPI 1831973056
- NPI 1215653944
- NPI 1073890661
- NPI 1003372327
- NPI 1710454855
- NPI 1518594787
- NPI 1265063929
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.